Documents
Application Sponsors
ANDA 206685 | MYLAN TECHNOLOGIES | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Prescription | 004 |
Prescription | 005 |
Application Products
001 | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.025MG/24HR | 0 | ESTRADIOL | ESTRADIOL |
002 | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.0375MG/24HR | 0 | ESTRADIOL | ESTRADIOL |
003 | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.05MG/24HR | 0 | ESTRADIOL | ESTRADIOL |
004 | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.075MG/24HR | 0 | ESTRADIOL | ESTRADIOL |
005 | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.1MG/24HR | 0 | ESTRADIOL | ESTRADIOL |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2018-08-15 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB3 |
002 | Prescription | AB3 |
003 | Prescription | AB3 |
004 | Prescription | AB3 |
005 | Prescription | AB3 |
CDER Filings
MYLAN TECHNOLOGIES
cder:Array
(
[0] => Array
(
[ApplNo] => 206685
[companyName] => MYLAN TECHNOLOGIES
[docInserts] => ["",""]
[products] => [{"drugName":"ESTRADIOL","activeIngredients":"ESTRADIOL","strength":"0.025MG\/24HR","dosageForm":"FILM, EXTENDED RELEASE;TRANSDERMAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ESTRADIOL","activeIngredients":"ESTRADIOL","strength":"0.0375MG\/24HR","dosageForm":"FILM, EXTENDED RELEASE;TRANSDERMAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ESTRADIOL","activeIngredients":"ESTRADIOL","strength":"0.05MG\/24HR","dosageForm":"FILM, EXTENDED RELEASE;TRANSDERMAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ESTRADIOL","activeIngredients":"ESTRADIOL","strength":"0.075MG\/24HR","dosageForm":"FILM, EXTENDED RELEASE;TRANSDERMAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ESTRADIOL","activeIngredients":"ESTRADIOL","strength":"0.1MG\/24HR","dosageForm":"FILM, EXTENDED RELEASE;TRANSDERMAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"08\/15\/2018","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/206685Orig1s000Lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"08\/15\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/206685Orig1s000Lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/206685Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2018-08-15
)
)